Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $150.3300 (1.76%) ($147.8000 - $150.8800) on Mon. Aug. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.32% (three month average) | RSI | 78 | Latest Price | $150.3300(1.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) SPLV(53%) DIA(51%) VYM(49%) SDY(47%) | Factors Impacting ABBV price | ABBV will decline at least -0.66% in a week (0% probabilities). VXX(-34%) VIXM(-32%) USO(-19%) TBT(-11%) BNDX(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.66% (StdDev 1.32%) | Hourly BBV | 1.5 () | Intraday Trend | 1.6% | | | |
|
5 Day Moving Average | $149.01(0.89%) | 10 Day Moving Average | $147.91(1.64%) | 20 Day Moving Average | $143.17(5%) | To recent high | -0.3% | To recent low | 13.4% | Market Cap | $265.225b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |